Molecular Biomarkers for the Treatment of Lung Cancer Personalized Therapy Beyond the EGFR Mutation
1 ODAC September 13 th, 2005 Tarceva ® (erlotinib) Adrian Senderowicz, M.D. DDODP, CDER FDA.
Takuro Wada , O Sato, A Kawai, T Hasegawa Sapporo Medial University , Sapporo Japan
